Both sides of the Fed’s dual mandate are in focus. Plus, Micron reports and Eli Lilly delivers updates on its obesity pipeline.
Both sides of the Fed’s dual mandate are in focus. Plus, Micron reports and Eli Lilly delivers updates on its obesity pipeline.
Sign in to your account